IRadimed Corporation (IRMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    IRadimed Corporation

    NASDAQ: IRMD · Real-Time Price · USD
    71.99
    -0.15 (-0.21%)
    At close: Sep 05, 2025, 3:59 PM
    71.99
    0.00%
    After-hours: Sep 05, 2025, 04:41 PM EDT

    IRadimed Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 73.24M 65.56M 53.3M 41.81M
    Cost of Revenue
    		 16.89M 15.4M 12.02M 9.76M
    Gross Profit
    		 56.35M 50.16M 41.28M 32.05M
    Operating Income
    		 21.96M 20.04M 15.63M 9.82M
    Interest Income
    		 2.19M 1.86M 581.85K 34.81K
    Pretax Income
    		 24.28M 21.74M 16.18M 9.84M
    Net Income
    		 19.23M 17.19M 12.83M 9.33M
    Selling & General & Admin
    		 31.55M 27.26M 23.38M 20.33M
    Research & Development
    		 2.83M 2.86M 2.28M 1.91M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 34.39M 30.12M 25.65M 22.23M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 15.62M 12.14M 12.68M 10.56M
    Cost & Expenses
    		 51.28M 45.53M 37.68M 32M
    Income Tax Expense
    		 5.04M 4.55M 3.35M 510.82K
    Shares Outstanding (Basic)
    		 12.67M 12.6M 12.56M 12.35M
    Shares Outstanding (Diluted)
    		 12.78M 12.72M 12.64M 12.59M
    EPS (Basic)
    		 1.52 1.36 1.02 0.76
    EPS (Diluted)
    		 1.50 1.35 1.02 0.74
    EBITDA
    		 22.78M 20.8M 16.3M 11.22M
    EBIT
    		 21.96M 20.04M 15.63M 9.84M
    Depreciation & Amortization
    		 817.66K 765.18K 670.67K 1.41M

    Add to Watchlist